When Martin Shkreli acquired the rights to Daraprim in 2015, a life-saving treatment for a parasitic infection, he raised the price to $750 per pill from the original $13.50.
For those who find this new price to be outrageously high, there’s good news.
A group of students from Sydney Grammar School recreated the drug for the low cost of $2 per dose. The students cannot sell the drug, however—making it nothing more than a science project.
You’d think Shkreli would be troubled about students reinventing his product for much cheaper, but his Twitter responses say otherwise.
On Thursday Shkreli posted a video to explain his reaction to the Australian students.
As of this writing, Shkreli remains unbothered by the development.